XBI Holdings5 Beaten-Down ETFs to Buy Now. 87. Looking at the chart above, XBI's low point in its 52 week range is $97. 0. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. 69% allocation. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Top Holdings . 2% Category Average. Looking at the chart above, XBI's low point in its 52 week range is $115. Based on its analysis of these factors, SSGA Funds Management, Inc. 31, 2021, are" XBI is an equal weight fund that rebalances each quarter. 5x and PE ratio is about 14x. 250-391-1110. Currency in USD. 12% in the. 66% so far this year and in the past. Total net assets. MTD. 58%: Halozyme Therapeutics Inc:How To Invest / Fund Directory / ARK Genomic Revolution ETF vs SPDR S&P Biotech ETF . In addition to holding 155 positions, its top 10 holdings make up just 14. Both BBH and XBI are ETFs. 01%). Cryptocurrency. Performance and Risk The ETF has lost about -29. 13%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. 15 during this last 52-week period. A few losers won't cause XBI to crash. Trades. 50. The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U. The top 10 holdings account for about 11. The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. Holdings. Trader's Guide 2024 Ships December 21st. Netherlands. 20 -4. 71%: Number of Holdings 64: Price/Book Ratio Price/Book Ratio. 7. 35% vs 0. XBI: SPDR S&P Biotech ETF - Fund Holdings. Complete SPDR S&P Biotech ETF funds overview by Barron's. 86% so far this year and is down about -32. 66 +2. While ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund's holdings is a valuable exercise. 35%). 78%) has been the biggest winner, with its shares jumping nearly 40% year to date. 12% in the. XLV comparisons: including fees, performance, dividend yield, holdings and technical indicators to make a better investment decision. 94 per share, with $116. Front end load. Dividend Yield. Nearly half of its holdings are early-stage players with no drug on the market yet and that therefore. Free ratings, analyses, holdings, benchmarks, quotes, and news. Plus view geographic exposure, currency. Net expense ratio. Holdings AS OF 04/30/2023. 96%, and is down about -5. 53 (+3. Summary. Get a real-time stock price quote for XBI (SPDR S&P BIOTECH ETF). 01 to $0. 09%: Canada: 1. Expense ratio and liquidity are average for the group. 81 and $97. 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. 79 as the 52 week high point — that compares with a last trade of $126. Cash and Equivalents. Skip to main content. ETF Channel Staff - Friday, October 20, 6:48 AM. IBB outperformed the S&P 500 last year and did much better than XBI. The fee is slightly higher for SBIO - . The top 10 holdings of XBI look like this: XBI Top 10 Holdings (morningstar. LABU has a higher expense ratio than XBI (1. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. Shares of XBI stock opened at $73. 2 %. The main reason for this is the additional risk mitigation an ETF provides given its myriad holdings within a sector. Advertisement. The Composition of the XBI is the Key. As illustrated more by the next two charts, comparing the top 10 holdings XBI and IBB. Growth of Hypothetical $10,000. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF stock was issued. 47 and a beta of 0. Discover historical prices for XBI stock on Yahoo Finance. Total healthcare and life sciences M&A was about $71. 9. Visitors trend 2W 10W 9M. The beaten-down prices offer a solid buying opportunity for investors. 1. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 06 as the 52 week high point — that compares with a last trade of $102. 2. 57 billion. Currency in USD. The top 10 holdings account for about 14. Below is the comparison between XBI and XLV. The Fund's prospectus and statement of additional information dated October 31, 2015, are incorporated by reference into this. The weighted harmonic average of closing market price divided by. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Looking at the chart above, XBI's low point in its 52 week range is $62. -listed equities in the biotechnology sector. It can be found in the fund’s most recent prospectus. 94 per share, with $121. Dividend ETFs. Total healthcare and life sciences M&A was about $71. 50. Again, top 10 holdings. 26%. XBI focuses on health care investments and follows the S&P Biotech Index. This is the case with most of XBI's holdings which do not yet have products at commercialization stage, except for notable exceptions including Moderna (NASDAQ: MRNA) and Regeneron (NASDAQ: REGN). S. 99%. com) BioCryst , Biohaven , Exelixis , and AbbVie make up the remainder of the top 5. 19%. Holdings. Brazil. The Health category average is 45. The company has an 88. The XBI underweights large cap biotechs and its top holdings include volatile smaller caps at about 1-2%. Last Price Today's Change Today's Volume : Prospectus. 15 billion. by Sweta Killa Published on September 18,2023. 191), IBB is significantly more concentrated in its top ten holdings than XBI. XBI / SPDR Series Trust - SPDR Biotech ETF short borrow fee rates are shown in the following table. 97. 5% on the day. 10 as of November 2, 2022. Additionally. 50 Bil, only including common equities, preferred equities, ETFs, options and warrants for equities. XBI has traded between $64. Top Ten Holdings as of 10/31/2023 Top 10 Holdings in XBI 16. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. IBB has 8. com. Get a real-time stock price quote for XBI (SPDR S&P BIOTECH ETF). 91 (11/14/23) 1 Day XBI 0. The fund's investments total to approximately $6. 35%). The fund has a beta of 0. 0. DLTR. 97. Visitors trend 2W 10W 9M. Up vote for PJP but it is pharmaceutical focused and technically not as broad as other biotech ETF's, though the top 10 holdings are comparable. View the real-time XBI price chart on Robinhood and decide if you want to buy or sell commission-free. ETF Strategies. 22%: Revolution. The ETF has a beta of 1. N/A. ARGX. 17% for the trailing three-year period, which makes XBI a high. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. The portfolio of Cathie Wood updated daily. XBI focuses on health care investments and follows the S&P Biotech Index. This type of methodology gives the smaller companies a greater importance in the fund thereby amplifying the gains and losses from small. XBI holdings. Components of. Top 10 Holdings 16. 06 and standard deviation of 38. The top 10 concentration is much higher than XBI at 38% given it only has 30 holdings compared to XBI's 140+ holdings. **Close price adjusted for splits and dividend and/or capital gain distributions. 01 to $0. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. 4% of the stocks in our database. Currency in USD Follow 2W 10W 9M 73. 35% for XBI, but SBIO yields 2. Royal Gold Inc. 2, 2023. $0. Across the 192 current stocks in the fund, all holdings have a weighting between 0. Sector ETFs. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. XBI – SPDR® S&P Biotech ETF – Check XBI price, review total assets, see historical growth, and review the analyst rating from Morningstar. View the latest ETF prices and news for better ETF investing. 81. 79 in February 2021 and has fallen over (50%) to $76. 42 billion worth of. SPDR SERIES TRUST's SPDR (R) S&P (R) Biotech ETF (XBI) has disclosed 141 total holdings in their latest N-PORT filing with the SEC for the portfolio date of 2023-06-30. In XBI, the top five holdings together represent only 9. 1% which highlights the scope of the fund and diversification away from company-specific risks. 2. 32% of the total portfolio assets. 00. 0. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. WisdomTree Cloud Computing Fund ETF holdings by MarketWatch. 84. Holdings. Thu, Nov 9, 1:16 PM ET, Market News Video. Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. Performance and Risk. XBI | A complete SPDR S&P Biotech ETF exchange traded fund overview by MarketWatch. Compare ETFs IBB and XBI on performance, AUM, flows, holdings, costs and ESG ratings. In addition to holding 155 positions, its top 10 holdings make up just 14. Top 10 Holdings. 39M), JPMorgan Chase & Co. LABD. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. SPDR® S&P Biotech ETF XBI. In trading on Monday the SPDR S&P Biotech ETF is outperforming other ETFs up about 2% on the day. argenx SE ADR. 0. SPDR S&P Biotech ETF. . 06 as the 52 week high point — that compares with a last trade of $102. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. Learn everything about iShares Biotechnology ETF (IBB). Both VHT and XBI are ETFs. L ooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P. As of 09/30/2023. 44 per share, with $92. Performance and Risk The ETF has lost about -3. 1. 79 as the 52 week high point — that compares with a last trade of $133. XBI provides a unique investment focus, as its holdings are largely small and mid-cap biotech firms rather than larger pharmaceutical companies such as Pfizer and Johnson & Johnson . 5%, and a 2. The table below compares many ETF metrics between IBB and XBI. Top 10 Holdings. 97% in the last one year (as of 11/07/2022). Holdings. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. More XBI Holdings Current Portfolio Date Nov 16, 2023; Equity Holdings 132; Bond Holdings 0;During the previous two years, 872 institutional investors and hedge funds held shares of SPDR S&P Biotech ETF. The stock holdings of the XBI tends to be re. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. Currency in USD Follow 2W 10W 9M 72. Index Dividend Yield The weighted average of the underlyings’ indicated annual dividend A high-level overview of SPDR® S&P Biotech ETF (XBI) stock. 51 on Tuesday. 12%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. 78% in the last one year. SPDR S&P Biotech ETF ETF holdings by MarketWatch. XBI has traded between $64. The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. While IBB has many more holdings than XBI (376 vs. NAV as of Nov 09, 2023. 9%. Free ratings, analyses, holdings, benchmarks, quotes, and news. The beaten-down prices offer a solid buying opportunity for investors. 3. Mean reversion is inevitable, and her ARKG fund was up something like 300% in 2020 (it was absolutely killing the market for a few years before then too). WIX. Compare ETFs XBI and IBB on performance, AUM, flows, holdings, costs and ESG ratings. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers. XLY News. Looking at the chart above, XBI's low point in its 52 week range is $62. Twin City Holdings Ltd from Port Alberni, BC. XBI: Head-To-Head ETF Comparison. 13%) Gold 1,980. Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment ResearchLearn how it impacts everything we do. The 10 largest holdings have a combined 17. Export data to Excel for your own analysis. 6738M. With about 156 holdings, it effectively. 57 billion. 53 (+3. We daily evaluate future near-term price gain prospects for quality, market-seasoned ETFs, based on the expectations of market. Rated on Jun 30, 2023 Published on Jun 30. 54%. Fund Size Comparison. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF stock was issued. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). 84%: Other: 0. ETF Summary. 38%. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). XBI has lost 27. The top holding in XBI receives just a 1. 86% upside for this ETF looking through to the average analyst targets of the underlying holdings. 15 per share, with $174. The first column indicates the name of each of the funds holding XBI, with a link to that fund's top holdings. 12% in the last one year (as. It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. XBI has traded between $62. Consumer Staples Select Sector SPDR ETF ETF holdings by MarketWatch. com) ReturnsXBI's top 10 holdings account for about 10. 9. Themes & Subsectors ETFs. 36% of total assets under management. 76% allocation. Looking at the chart above, XBI's low point in its 52 week range is $63. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. 2% Top Ten Holdings. While this ETF allocates. Assets Under Management. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. All 33 ARKK ETF Holdings. 78% of XBI's total assets under management. SPDR S&P Biotech ETF is a equity fund issued by SSgA. XBI. Top 10 Holdings (16. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. $0. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. XBI currently has 133 holdings. LABU. 46M), Matrix Capital Management Company LP ($188. Company Change % Net. $36. 84 Billion in assets under management, while XBI has 4. 37% in the last one. 10(-0. 64 per share, with $174. Snapshot for the SPDR S&P BIOTECH ETF ETF (XBI), including recent quote, performance, objective, analyst opinions, and commentary. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. Looking at the chart above, XBI's low point in its 52 week range is $100. 94 per share, with $107. In a true biotech bust, where investors can't bear the thought of owning a biotech company ever again, there's little to stop XBI from falling to a near 1 P/B ratio when 80% of its top holdings. The "A+ Metric Rated ETF" field, available to ETF Database Pro members, highlights the best rated ETF in the Emerging Markets Equities category. The famed investor's Berkshire Hathaway (. View Top Holdings and Key Holding Information for Direxion Daily S&P Biotech Bull 3X Shares (LABU). Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 33% from the latest price. Summary From a population of some 350 actively-traded, substantial, and growing ETFs this is a currently attractive addition to a portfolio whose principal objective is wealth accumulation by active investing. XBI focuses on a narrow sector of the health care sector, and as such is probably too precise for most investors. Unlock comprehensive insights, track. 20. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 64% for the trailing three-year period, making it a high risk. 97. Both BBC and XBI are ETFs. 01% upside for this ETF looking through to the average analyst targets of the underlying holdings. Below is the comparison between ARKG and XBI. 35%. There is no guarantee the fund will achieve its stated investment objective. Notable ETF Outflow Detected - XBI, CYTK, CCXI, SRPT. One of the most popular entries among the best biotech ETFs to buy, the SPDR S&P Biotech ETF (NYSEARCA:XBI) benefits from strong volume metrics. 06 as the 52 week high point — that compares with a last trade of $109. 08 per unit, that means that analysts see 59. Fund Analysis. There is no overlap of the top 10 holdings between SBIO and XBI. Currency in USD Follow 2W 10W 9M 72. The. XLV. XBI’s Holdings. XBI comparisons: including fees, performance, dividend yield, holdings and technical indicators to make a better investment decision. S. 24 per unit, that means that analysts see 75. News, commentary and events are from third-party sources unaffiliated with Fidelity. The iShares Biotechnology ETF seeks to track the investment results of an index composed of U. In addition to holding 155 positions, its top 10 holdings make up just 14. 26% rating in the component of Value. It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. 50% vs. Consumer Staples Select Sector SPDR ETF ETF holdings by MarketWatch. Performance and Risk So far this year, XBI has added roughly 1. Holding Companies. SGEN. XBI - SPDR (R) S&P (R) Biotech ETFs top. The following charts reflect the geographic spread of WCLD's underlying holdings. TipRanks | Stock Market Research, News and Analyst Forecasts. According to data from U. XBI's top 10 holdings account for about 11. According to data from U. Meanwhile, XBI equal weights its holdings. 67% Top 10 holdings are 16. XBI has a beta of 0. The sale of ETFs is subject to an activity assessment fee (from $0. 58 💸. 04 per unit, that means that analysts see 73. A few losers won't cause XBI to crash. IBB vs. ($423. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. 5% year-to-date and 38. XBI's 120. As of the latest information, Bullfrog AI Holdings will launch its initial public offering ( IPO) — or the first time a private enterprise distributes its equity shares to retail (public. VHT has a. I have thoroughly reviewed the holdings of the XBI and have come away impressed with how broad-based the composition of the ETF is. •. Seeking AlphaXBI vs. Mirati Therapeutics. $72. XBI is suitable for investors seeking to. SPDR® S&P Biotech ETF XBI: NYSE Arca . Performance and Risk. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. View complete WCLD exchange traded fund holdings for better informed ETF trading. 41% so far this year and in the past one year (as of 01/23/2023), respectively. 35% ; Sectors:. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. Quote. View complete YINN exchange traded fund holdings for better informed ETF trading. Discover historical prices for XBI stock on Yahoo Finance. 81. 56% vs 0. 96%, and is down about -5. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. Looking at the chart above, XBI's low point in its 52 week range is $100. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. TG Therapeutics Inc TGTX:US. Below is the comparison between VHT and XBI. In trading on Thursday the Uranium ETF is outperforming other ETFs up about 3. BIIB is also in the top 15 XBI holdings. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy.